This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
An analysis of Q2's venture capital deals and investment activity in Southern California find that venture capitalists invested around $1.6 billion invested in Q1, and up from $1.0 in investment), Energy ($190.2M in investments) and Medical Deviecs ($128.1M in investments in Q2).
Southern California venture capitalinvestments totaled $686.5M According to the report, released today, Southern California investments totaled $686.5M Southern California's investment totals bucked the national trend, which found that there was a 9 percent drop in dollars to $4.7 in 29 venture capital deals for Q1.
The latest numbers from the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association (NVCA), based on data from Thomson Reuters, were released this morning, finding that there was $587.8M invested in Southern California in Q4. was invested in the region. in investments.
The latest numbers from the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association (NVCA), based on data from Thomson Reuters, were released this morning, finding that there was $587.8M invested in Southern California in Q4. was invested in the region. in investments.
Torrance-based Pathology, Inc. , a provider of pathology and molecular diagnostics services, has received a Series A investment, according to lead investor ABS Capital Partners. will use the funding to retire founding shareholders, as well as for growth and and investment in new technologies. ABS said that Pathology, Inc.
The October funding of Torrance-based Pathology, Inc. The firm had announced the Series A investment from ABS Capital Partners in October. Tags: capital venture pathology. was worth $24.65M, according to new numbers revealed over the weekend in the PricewaterhouseCoopers/NVCA MoneyTree report. Pathology, Inc.
Torrance-based Amonix , a developer of concentrated photovoltaic power generation systems for the utility industry, has hit $104.4M No details of the funding have been announced by the firm, which is backed by private equity firm MissionPoint Capital Partners. Cirilli, former Chief Investment Officer of Marshall Street Management.
Torrance-based BQE said on Wednesday that it has received a "significant investment" from private equity investor Serent Capital. Financial details of the investment were not announced. Serent Capital is a private equity investor that invests in technology and tech-enabled software companies.
As part of the funding, the two said that Alger, BVF Partners LP and OrbiMed have entered into a securities purchase agreement to invest $14 million in the combined company. The newly merged company will operate under the name Forte Biosciences, and trade on the Nasdaq Capital Market as FBRX. READ MORE>>.
Torrance-based Phyn , the developer of the remarkably advanced water monitoring technology spun out of Belkin, said today that it has raised another $10M in funding, from current investor Uponor. According to Phyn, the new investment will go towards market penetration and to scale the company's operations.
Meanwhile, TechCrunch reporter Manish Singh learned from two sources familiar with the deal that Bangalore-based startup Bounce has raised about $150 million as part of an ongoing financing round led by existing investors Eduardo Saverin’s B Capital and Accel Partners India. We hear a lot. But we’re not selfish. Let’s share.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content